METHOD AND PHARMACEUTICAL TO TREAT SPINAL DISCS
First Claim
1. A method of reducing chronic pain caused by a disrupted spinal disc comprising injecting a physiologically acceptable amount of an injectable into said disc, the injectable comprising:
- a stock solution comprising;
chondroitin sulphate, between about 0.5% to about 2.0%;
glucosamine HCl, between about 5.0% to about 20.0%;
aqueous solution of dextrose;
sodium carboxymethylcellulose between about 0.5% to about 2.0%; and
a buffer substance in quantity to bring the pH of the stock solution to a value above about 6.0; and
water to dilute the stock solution.
1 Assignment
0 Petitions
Accused Products
Abstract
Methods for reducing chronic pain caused by a disrupted spinal disc are described. In one method, a physiologically acceptable amount of an injectable is injected into the disc. The injectable is obtained from a stock solution comprising chondroitin sulphate, glucosamine HCl, aqueous solution of dextrose; sodium carboxymethylcellulose, and a buffer substance in quantity to bring the pH of the stock solution to a value above about 6.0. Water is also added to dilute the stock solution. The stock solution may further comprise an anesthetic such as bupivicaine.
33 Citations
20 Claims
-
1. A method of reducing chronic pain caused by a disrupted spinal disc comprising injecting a physiologically acceptable amount of an injectable into said disc, the injectable comprising:
-
a stock solution comprising; chondroitin sulphate, between about 0.5% to about 2.0%; glucosamine HCl, between about 5.0% to about 20.0%; aqueous solution of dextrose; sodium carboxymethylcellulose between about 0.5% to about 2.0%; and a buffer substance in quantity to bring the pH of the stock solution to a value above about 6.0; and water to dilute the stock solution. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)
-
-
13. A method of reducing chronic pain caused by a disrupted spinal disc comprising injecting a physiologically acceptable amount of an injectable into said disc, the injectable comprising:
-
a stock solution comprising; chondroitin sulphate, between about 0.5% to about 2.0%; glucosamine HCl, between about 5.0% to about 20.0%; and aqueous solution of dextrose; and water to dilute the stock solution. - View Dependent Claims (14, 15, 16, 17, 18, 19, 20)
-
Specification